Sivik Global Healthcare LLC bought a new position in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 25,000 shares of the medical equipment provider’s stock, valued at approximately $2,927,000.

A number of other institutional investors also recently bought and sold shares of ZBH. State of Alaska Department of Revenue grew its holdings in Zimmer Biomet Holdings by 32.2% during the second quarter. State of Alaska Department of Revenue now owns 5,588 shares of the medical equipment provider’s stock worth $717,000 after acquiring an additional 1,360 shares during the period. National Pension Service grew its holdings in Zimmer Biomet Holdings by 10.5% during the second quarter. National Pension Service now owns 179,271 shares of the medical equipment provider’s stock worth $22,927,000 after acquiring an additional 17,082 shares during the period. Baldwin Brothers Inc. MA grew its holdings in Zimmer Biomet Holdings by 0.4% during the second quarter. Baldwin Brothers Inc. MA now owns 13,745 shares of the medical equipment provider’s stock worth $1,765,000 after acquiring an additional 60 shares during the period. Jacobs & Co. CA grew its holdings in Zimmer Biomet Holdings by 3.7% during the second quarter. Jacobs & Co. CA now owns 38,486 shares of the medical equipment provider’s stock worth $4,941,000 after acquiring an additional 1,384 shares during the period. Finally, Mn Services Vermogensbeheer B.V. grew its holdings in Zimmer Biomet Holdings by 508.7% during the second quarter. Mn Services Vermogensbeheer B.V. now owns 32,518 shares of the medical equipment provider’s stock worth $4,175,000 after acquiring an additional 27,176 shares during the period. 85.36% of the stock is currently owned by hedge funds and other institutional investors.

WARNING: “25,000 Shares in Zimmer Biomet Holdings, Inc. (ZBH) Acquired by Sivik Global Healthcare LLC” was originally posted by Watch List News and is owned by of Watch List News. If you are viewing this article on another domain, it was illegally stolen and republished in violation of international copyright & trademark legislation. The original version of this article can be accessed at https://www.watchlistnews.com/25000-shares-in-zimmer-biomet-holdings-inc-zbh-acquired-by-sivik-global-healthcare-llc/1722266.html.

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) traded down $0.49 during midday trading on Thursday, hitting $113.07. The stock had a trading volume of 785,800 shares, compared to its average volume of 1,359,135. The stock has a market capitalization of $22,790.00, a P/E ratio of 14.07, a PEG ratio of 1.76 and a beta of 1.17. Zimmer Biomet Holdings, Inc. has a 1-year low of $99.11 and a 1-year high of $133.49. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.78 and a current ratio of 1.47.

Zimmer Biomet Holdings (NYSE:ZBH) last released its earnings results on Wednesday, November 1st. The medical equipment provider reported $1.72 earnings per share for the quarter, missing the consensus estimate of $1.74 by ($0.02). The firm had revenue of $1.82 billion during the quarter, compared to analysts’ expectations of $1.83 billion. Zimmer Biomet Holdings had a net margin of 8.36% and a return on equity of 16.29%. The business’s revenue was down .8% compared to the same quarter last year. During the same quarter last year, the business earned $1.79 EPS. research analysts forecast that Zimmer Biomet Holdings, Inc. will post 8.03 EPS for the current fiscal year.

Several analysts recently commented on the company. Oppenheimer Holdings, Inc. set a $137.00 target price on Zimmer Biomet Holdings and gave the stock a “buy” rating in a report on Friday, July 28th. Piper Jaffray Companies reiterated a “buy” rating and set a $135.00 price target on shares of Zimmer Biomet Holdings in a research report on Friday, July 28th. Canaccord Genuity downgraded Zimmer Biomet Holdings from a “buy” rating to a “hold” rating and lowered their price target for the stock from $141.00 to $135.00 in a research report on Friday, July 28th. Cantor Fitzgerald set a $137.00 price target on Zimmer Biomet Holdings and gave the stock a “hold” rating in a research report on Thursday, July 27th. Finally, BMO Capital Markets increased their price target on Zimmer Biomet Holdings from $136.00 to $140.00 and gave the stock an “outperform” rating in a research report on Friday, July 28th. Four research analysts have rated the stock with a sell rating, seven have given a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the stock. Zimmer Biomet Holdings has a consensus rating of “Hold” and an average target price of $133.71.

About Zimmer Biomet Holdings

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Institutional Ownership by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)

Receive News & Ratings for Zimmer Biomet Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet Holdings Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.